Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

Kei Moriya, Tadashi Namisaki, Shinya Sato, Masanori Furukawa, Akitoshi Douhara, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Yasuhiko Sawada, Soichiro Saikawa, Hiroaki Takaya, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji

Clin Mol Hepatol. 2019;25(4):381-389. Published online August 13, 2019

DOI: https://doi.org/10.3350/cmh.2019.0037

View: 6235 Download: 141 Web of Science: 14 Crossref: 12

Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis

Hyun Young Woo, Jun Mo Youn, Si Hyun Bae, Jeong Won Jang, Jung Hoon Cha, Hye Lim Kim, Ho Jong Chun, Byung Gil Choi, Jong Young Choi, Seoung Kew Yoon

Clin Mol Hepatol. 2012;18(1):32-40. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.32

View: 8219 Download: 49 Crossref: 11

3

Efficacy of Hepatic Arterial Infusion Therapy for Advanced Hepatocellular Carcinoma Using 5-fluorouracil and Cisplatin

Byoung Kuk Jang , Ki Min Kwon , Woo Jin Chung , Kyung Sik Park , Kwang Bum Cho , Jae Seok Hwang , Sung Hoon Ahn , Gab Chul Kim , Young Hwan Kim , Jin Soo Choi , Jung Hye

Clin Mol Hepatol. 2004;10(4):271-278.

View: 2642 Download: 27

Concurrent Chemo - Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis

Jin Suk Kim, M.D., Kwang-Hyub Han, M.D., Do Yun Lee, M.D.* , Jin-Sil Seong, M.D.† , Young Hoon Youn, M.D., Jae Youn Cheong, M.D., Sang Hoon Ahn, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.

Clin Mol Hepatol. 2002;8(1):71-79. Published online January 1, 1970

View: 3129 Download: 19

1 |

Viewed By 5975	MAFLD: How is it different from NAFLD?
Viewed By 4882	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4628	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 3442	Gut microbiome and metabolome signatures in liver cirrhosis-related complications
Viewed By 2908	Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Cited By 283	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 234	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 157	MAFLD: How is it different from NAFLD?
Cited By 82	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search